Eyal Gimshi
Theranostics General Manager
“כָּל הָעוֹלָם כֻּלוֹ גֶשֶׁר צַר מְּאֹד וְהָעִיקָר לֹא לְפַחֵד כְּלַל”
[ר’ נחמן מברסלב]
“The whole world is a very narrow bridge, but the important thing is not to fear at all”
[Rabbi Nachman of Braslav]
————
Eyal makes the impossible possible. In believing so, Eyal drives the Global Business division of Isotopia to new horizons, making the vision a reality.
Eyal is leading ISOTOPIA’s therapeutics, responsible for global commercial operations while ensuring compliant, advanced, and efficient production and supply chain of ISOTOPIA’s radiopharmaceuticals.
Eyal has been with ISOTOPIA since its inception and has gained extensive expertise in the production, logistics and commercialization of radiopharmaceuticals.
He has led and managed key engineering and manufacturing processes, including the construction of the company’s radio-pharmacy and PET facility with a focus on cyclotron and Gallium-68 based radiopharmaceuticals.
Eyal received his BSc. in Nuclear Engineering from the Ben-Gurion University and holds both an MSc in Nuclear Engineering and an MBA in Business Administration.